Administration of a neutralizing anti-Tim3 antibody (clone 8H7), although ineffective when administered during an OVA sensitization and challenge model of asthma, was able to induce a partial decrease in AHR and Th2 cytokine production following the transfer of OVA-specific in vitro differentiated Th2 cells [16]. This evidence concerns the gene HAVCR2 and asthma.